EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 01:15 ET (22-Jun-2026 05:15 GMT/UTC)

University of Maryland Greenebaum Comprehensive Cancer Center receives $3 million NCI Award to develop next generation of cancer researchers

University of Maryland School of Medicine
Grant and Award Announcement

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has been awarded a prestigious $3 million National Cancer Institute (NCI) Career Development Award to train the next generation of oncology researchers focused on treating patients of all backgrounds.

UNC researchers publish findings in JAMA Network Open about impact of diagnostic wait time on ovarian cancer survival

UNC Gillings School of Global Public Health
Peer-Reviewed Publication

The study "Diagnostic Timing and Ovarian Cancer Survival in North Carolina" has been published in the latest issue of JAMA Network Open. Led by a team of UNC researchers, this study explored the relationship between survival and how quickly patients are diagnosed with ovarian cancer.

Journal: JAMA Network Open

Lasting income costs of mental and physical illness

JAMA Network
Peer-Reviewed Publication

About The Study: This study estimated income losses from the individual perspective in the 10 years following hospital diagnosis of depression, alcohol use disorder, stroke, and breast cancer from 2000 to 2023 in Denmark. The researchers found that (1) income losses following mental disorder diagnoses were larger than those for physical conditions, though all evaluated diseases led to substantive loss; (2) average losses grew in years following diagnosis, particularly among individuals younger than 40 and those in school, suggesting accumulating disadvantage; and (3) even those outside of the workforce at the time of hospital diagnosis experienced sustained future income loss.

Journal: JAMA Health Forum

Artificial intelligence learns to make sense of childhood cancer survivors’ health care needs

St. Jude Children's Research Hospital
Peer-Reviewed Publication

St. Jude Children’s Research Hospital scientists studied how prompting styles influence artificial intelligence’s ability to analyze interviews and identify childhood cancer survivors needing extra support.

Journal: Communications Medicine

MSK Research Highlights, March 27, 2026

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

New research from Memorial Sloan Kettering Cancer Center (MSK) finds skin stem cells retain long-lasting memory of inflammation; shows how a large cancer DNA study could transform personalized oncology; reveals how the protein BAF helps cancer cells hide from the immune system; and investigates how early DNA markings shape cell fate.

Molecular test doubles detection of bile duct cancer

University of Pittsburgh
Peer-Reviewed Publication

Scientists at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine developed BiliSeq, a molecular test that detected bile duct cancer with twice the sensitivity of the standard test, giving physicians a more accurate picture of the patient’s diagnosis.

Journal: Gastroenterology
Funder: National Pancreas Foundation, Sky Foundation, Pancreatic Cancer Action Network

Damon Runyon scientists gather for 2026 Accelerating Cancer Cures Symposium

Damon Runyon Cancer Research Foundation
Meeting Announcement

Damon Runyon scientists and industry partners gathered on Tuesday, March 24, for the 2026 Accelerating Cancer Cures Research Symposium, hosted by Amgen in Cambridge, Massachusetts.

Simple tumor biomarker test predicts which stomach cancer patients will respond to immunotherapy

Science China Press
Peer-Reviewed Publication

Chinese researchers identified tumor-specific MHC-II (tsMHC-II) expression as a novel biomarker predicting response to neoadjuvant immunotherapy in gastric cancer. Single-cell profiling revealed higher MHC-II expression in tumor cells from treatment-sensitive patients. Validated in prospective trials, tsMHC-II-positive patients achieved 36.67% pathological complete response rate versus low rates in unselected populations. This simple immunohistochemistry-based biomarker outperforms current PD-L1 assessment and could guide personalized therapy for gastric cancer patients.

Journal: Science Bulletin

Emerging light-powered cancer treatment gets a nanotech upgrade

Higher Education Press
Peer-Reviewed Publication

This article explores recent advances in liposomal nanotechnology for photodynamic therapy, showing how improved drug loading, targeting, and light-activated efficiency are enhancing cancer treatment outcomes.

Journal: Frontiers of Optoelectronics

Snail inspired soft robots to transform precision drug delivery in bowel cancer

University of Manchester
Grant and Award Announcement

Manchester researchers have secured nearly £1 million from UKRI to develop miniature snail inspired soft robots capable of delivering anti cancer drugs with unprecedented precision inside the human body.